日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/01/12 | 7,880 | 8,010 | 7,860 | 7,970 | +190 | +2.4% | 141,600 |
| 2022/01/11 | 7,830 | 7,870 | 7,710 | 7,780 | -10 | -0.1% | 171,800 |
| 2022/01/07 | 7,840 | 7,920 | 7,760 | 7,790 | -100 | -1.3% | 157,500 |
| 2022/01/06 | 7,870 | 7,920 | 7,840 | 7,890 | -70 | -0.9% | 168,800 |
| 2022/01/05 | 7,990 | 8,060 | 7,920 | 7,960 | -70 | -0.9% | 198,800 |
| 2022/01/04 | 8,060 | 8,070 | 7,920 | 8,030 | +20 | +0.2% | 133,400 |
| 2021/12/30 | 8,030 | 8,110 | 8,010 | 8,010 | -80 | -1% | 79,400 |
| 2021/12/29 | 8,210 | 8,210 | 7,970 | 8,090 | -120 | -1.5% | 144,000 |
| 2021/12/28 | 8,120 | 8,260 | 8,090 | 8,210 | +90 | +1.1% | 91,100 |
| 2021/12/27 | 8,100 | 8,160 | 8,070 | 8,120 | ±0 | ±0% | 61,500 |
| 2021/12/24 | 8,190 | 8,210 | 8,050 | 8,120 | -60 | -0.7% | 99,500 |
| 2021/12/23 | 8,330 | 8,340 | 8,150 | 8,180 | -40 | -0.5% | 109,900 |
| 2021/12/22 | 8,120 | 8,220 | 8,080 | 8,220 | +100 | +1.2% | 178,500 |
| 2021/12/21 | 8,100 | 8,190 | 8,040 | 8,120 | +160 | +2% | 149,100 |
| 2021/12/20 | 7,790 | 7,960 | 7,780 | 7,960 | +110 | +1.4% | 155,700 |
| 2021/12/17 | 8,080 | 8,120 | 7,800 | 7,850 | -270 | -3.3% | 266,800 |
| 2021/12/16 | 8,120 | 8,170 | 8,080 | 8,120 | +80 | +1% | 128,000 |
| 2021/12/15 | 8,020 | 8,120 | 8,010 | 8,040 | -50 | -0.6% | 134,400 |
| 2021/12/14 | 8,100 | 8,210 | 8,080 | 8,090 | ±0 | ±0% | 134,700 |
| 2021/12/13 | 8,210 | 8,240 | 8,080 | 8,090 | +10 | +0.1% | 109,100 |
| 2021/12/10 | 8,200 | 8,210 | 8,060 | 8,080 | -130 | -1.6% | 137,400 |
| 2021/12/09 | 8,260 | 8,340 | 8,210 | 8,210 | -200 | -2.4% | 97,300 |
| 2021/12/08 | 8,500 | 8,560 | 8,380 | 8,410 | +60 | +0.7% | 183,900 |
| 2021/12/07 | 8,130 | 8,380 | 8,080 | 8,350 | +200 | +2.5% | 130,500 |
| 2021/12/06 | 8,210 | 8,300 | 8,140 | 8,150 | -70 | -0.9% | 104,500 |
| 2021/12/03 | 8,130 | 8,220 | 8,040 | 8,220 | +60 | +0.7% | 170,700 |
| 2021/12/02 | 8,190 | 8,260 | 8,160 | 8,160 | -70 | -0.9% | 174,100 |
| 2021/12/01 | 8,360 | 8,390 | 8,160 | 8,230 | -170 | -2% | 245,500 |
| 2021/11/30 | 8,520 | 8,660 | 8,400 | 8,400 | -120 | -1.4% | 467,500 |
| 2021/11/29 | 8,620 | 8,690 | 8,490 | 8,520 | -90 | -1% | 161,500 |
| 2021/11/26 | 8,810 | 8,860 | 8,540 | 8,610 | -200 | -2.3% | 124,400 |
| 2021/11/25 | 8,770 | 8,920 | 8,710 | 8,810 | +110 | +1.3% | 110,900 |
| 2021/11/24 | 8,650 | 8,720 | 8,590 | 8,700 | -60 | -0.7% | 110,800 |
| 2021/11/22 | 8,620 | 8,800 | 8,600 | 8,760 | +140 | +1.6% | 96,100 |
| 2021/11/19 | 8,720 | 8,730 | 8,560 | 8,620 | -50 | -0.6% | 119,700 |
| 2021/11/18 | 8,750 | 8,790 | 8,600 | 8,670 | -160 | -1.8% | 85,700 |
| 2021/11/17 | 9,010 | 9,090 | 8,800 | 8,830 | -150 | -1.7% | 82,900 |
| 2021/11/16 | 8,750 | 9,020 | 8,750 | 8,980 | +110 | +1.2% | 146,100 |
| 2021/11/15 | 8,900 | 8,900 | 8,720 | 8,870 | +50 | +0.6% | 150,900 |
| 2021/11/12 | 8,620 | 8,880 | 8,580 | 8,820 | +200 | +2.3% | 175,300 |
| 2021/11/11 | 8,920 | 8,920 | 8,550 | 8,620 | -330 | -3.7% | 205,400 |
| 2021/11/10 | 9,020 | 9,040 | 8,930 | 8,950 | -80 | -0.9% | 87,400 |
| 2021/11/09 | 9,090 | 9,100 | 8,970 | 9,030 | -30 | -0.3% | 88,400 |
| 2021/11/08 | 9,320 | 9,320 | 9,040 | 9,060 | -300 | -3.2% | 106,900 |
| 2021/11/05 | 9,270 | 9,360 | 9,210 | 9,360 | ±0 | ±0% | 83,000 |
| 2021/11/04 | 9,450 | 9,470 | 9,300 | 9,360 | +150 | +1.6% | 180,400 |
| 2021/11/02 | 9,230 | 9,280 | 9,200 | 9,210 | -110 | -1.2% | 85,700 |
| 2021/11/01 | 9,280 | 9,330 | 9,200 | 9,320 | +210 | +2.3% | 100,600 |
| 2021/10/29 | 9,020 | 9,150 | 8,940 | 9,110 | +90 | +1% | 169,800 |
| 2021/10/28 | 9,170 | 9,180 | 8,970 | 9,020 | -120 | -1.3% | 603,500 |
801～
850
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 358,000円 | +7.9% | +8.9% | 3.46% | 7.66倍 | 1.03倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 63,300円 | +21.1% | - | 0.00% | 15.72倍 | 2.20倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| サワイＧＨＤ | 195,000円 | +4.0% | +25.4% | 2.72% | 8.53倍 | 1.11倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 187,300円 | +5.0% | +1.5% | 0.00% | 16.08倍 | 4.28倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 科研薬 | 405,000円 | +30.5% | +111.0% | 4.69% | 11.41倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
